As of 2022, the company started to work on transforming PharmUp into a Turkey-based multi-stakeholder entrepreneurship platform in order to take the project further and increase global competitiveness in the field of healthcare in our country and strengthen the innovation ecosystem. In this context, the PharmUp Hub Platform, one of Turkey’s largest innovation interfaces in the field of digital health, was launched. Under the umbrella of PharmUp Hub, Sanofi Turkey signed an important collaboration with Türk Telekom’s corporate venture capital company TT Ventures that will strengthen the entrepreneurial ecosystem in the healthcare field.
Within the scope of the cooperation, it is aimed to support project development processes for entrepreneurs and to turn value-added innovation and technology-based projects into products by creating a scientific platform. Potential initiatives within the scope of Sanofi Turkey’s TT Ventures cooperation; They will be able to benefit from the office workspaces offered by TT Ventures, the mentorship support, and the know-how to turn the ideas of startups into products and services. After the cooperation process that started between the two institutions, the platform; It is aimed to expand with the participation of technoparks, joint incubation centers and the private sector.
Cem Ozturk
Sanofi Turkey Country President and Sanofi Turkey, Africa and Middle East Core Products President
Sanofi Turkey Country President and Sanofi Turkey, Africa and Middle East Core Products President Cem Öztürk said, “Since 2019, we have been bringing together entrepreneurs from every field and sector that can develop solutions for the health sector with the PharmUp entrepreneurship program. As of this year, we have transformed the program into the PharmUp Hub innovation platform, which provides laboratories, thematic innovation programs, workshops, expert support and information resources to start-ups in cooperation with universities and incubators, as well as corporate partnerships. Our cooperation with TT Ventures is an important step towards realizing our goal. We are happy that we will create value for both the entrepreneurs in the field of health and the national economy with the support of this cooperation.”
Mohammed Ozhan
General Manager of TT Ventures
Muhammed Özhan, General Manager of TT Ventures, said: “As Türk Telekom’s corporate venture capital company, TT Ventures, we continue our efforts to contribute to the growth of the entrepreneurship ecosystem. We aim to contribute to the country’s economy by supporting initiatives with innovative products. 104 startups have graduated from PILOT, the industry’s first startup acceleration program under TT Ventures, and 45 of these startups have received outside investment. On the other hand, as TT Ventures, we have invested in 13 different ventures. We especially focus on areas that will create synergy with Türk Telekom such as health, education, artificial intelligence, digital solutions, financial technologies, blockchain, IOT and ICT. In this sense, we attach great importance to this collaboration with Sanofi, an important global health company, in the field of digital health. We are happy to create new opportunities by supporting ideas that will add value to the health sector within the scope of PharmUp program through TT Ventures Venture Capital Fund and PILOT. In this context, we believe that this cooperation, which will start with Sanofi, will go outside of Turkey and find a place in the global arena in the near future. As TT Ventures, we will continue to develop the entrepreneurship ecosystem by adapting our technological know-how to different projects, with the aim of being a bridge that opens startups to the world.”
Within the scope of Sanofi Turkey PharmUp Hub entrepreneurship program, it continues to contribute to the entrepreneurship ecosystem with its collaborations with Başakşehir Living Lab, Teknopark İstanbul and Lokman Hekim University Health and Pharmaceutical Technology Center (LHUSTEK) and now with TT Ventures.
About Sanofi
As an innovative global healthcare company, we are driven by our purpose: We pursue the miracles of science to improve human life. Our employees in nearly 100 countries around the world provide healthcare solutions that make the impossible possible, working to advance the practice of medicine. While putting sustainability and social responsibility at the center of our strategy, we provide health solutions and life-saving vaccines that have changed the fate of millions of patients around the world.
Sanofi is traded on EURONEXT: SAN and NASDAQ: SNY.
About PharmUp Hub
As Sanofi Turkey, with the PharmUp Entrepreneurship Program that we launched in 2019, we have been successfully bringing together entrepreneurs from every field and sector who can develop solutions for the health sector for 3 years. A total of 173 entrepreneurs applied to the program we run together with Endeavor Turkey in 3 years. Among these applications, 16 entrepreneurs selected for the program had the chance to participate in the acceleration period of PharmUp. As of 2022, we have started to work on transforming PharmUp into a Turkey-based multi-stakeholder entrepreneurship platform in order to increase global competitiveness in the field of healthcare in our country and strengthen the innovation ecosystem by moving the project forward. We have implemented the PharmUp Hub Platform, one of Turkey’s largest innovation interfaces in the field of digital health. The common goal of all partners who are/will be included in the PharmUp Hub platform is to focus on patient needs; It will create an interdisciplinary innovation ecosystem with the cooperation of governance, health finance, technology and data expertise and support the development processes of health entrepreneurs from incubation to market access.